One Year Since Our CMO/CDMO of the Year Award
One year after receiving the CMO/CDMO of the Year Award at the Advanced Therapies Awards in Dallas.
Yesterday marked one year since VIVEbiotech was named CMO/CDMO of the Year Award at the Advanced Therapies Awards, held during Advanced Therapies Week 2025 in Dallas. It was a moment that filled us with pride and genuine excitement — and it still does today.
Looking back, we remember the joy, the gratitude, and the sense of appreciation we felt. The award acknowledged the dedication of our team, the trust of our partners, and our ongoing effort to support the advanced therapy community.
As we revisit that moment, we want to once again thank Phacilitate and everyone who has supported us along the way. Your confidence continues to motivate us to keep improving and to give our best every day.
This recognition was — and continues to be — a reminder of the passion and commitment you bring to our mission.
With the same enthusiasm, we look forward to continuing to grow together and contributing to the future of advanced therapies.